Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC MRE 3008F20 252979-43-4 10mg
Supplier: Apexbio Technology LLC B551810
MRE 3008F20 is a small-molecule antagonist targeting the TRAIL receptor signaling pathway It is designed to inhibit activation of the TRAIL receptor thereby blocking tumor necrosis factor-related apoptotic processes MRE 3008F20 exerts its biological activity by specifically binding to the ligand-binding site of the TRAIL receptor (TRAIL-R) preventing receptor activation and inhibiting downstream apoptosis signaling events Based on these pharmacological properties MRE 3008F20 holds research potential in cell biology assays oncology pharmacology studies and investigations using disease-relevant cellular and animal models
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?